News & Perspective

Sep 26, 2016

Sep 26, 2016
Aedes aegypti mosquito

Four suspected Zika microcephaly cases in Thailand

Also, Florida, the Philippines, and Singapore report more locally acquired cases.

Sep 20, 2016

Sep 20, 2016

CDC ups Zika testing support; Florida reports more local cases

In other developments, without Zika funding federal officials have had to tap research money for cancer and other diseases.

Sep 08, 2016

Sep 08, 2016
mosquito duo

Protests delay Miami Zika spraying as funding talks continue

Also, Singapore said it's not clear yet if the Asian strain involved in its local spread will result in the severe complications.

Sep 01, 2016

Sep 01, 2016
Dead mosquitoes

Mosquitoes in Miami Beach test positive for Zika

Also, the WHO said samples from Guinea-Bissau are part of the African lineage, not the Americas one.

Apr 22, 2008

Apr 22, 2008

HHS official reports on Southeast Asia issues

(CIDRAP News) – A US Department of Health and Human Services (HHS) official today shared wrap-up perspectives on HHS Secretary Mike Leavitt's recent trip to Southeast Asia, which included discussions on virus-sharing and restrictions on the US Navy laboratory in Indonesia, updates on avian influenza collaborations, and talks on import safety.

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Oct 25, 2007

Oct 25, 2007

THE PANDEMIC VACCINE PUZZLE Bibliography

Editor's note: This is the bibliography to a seven-part series launched October 25, 2007, investigating the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. The series puts advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Oct 17, 2006

Oct 17, 2006

Baxter says cell-based H5N1 vaccine shows potential in trial

(CIDRAP News) – Low doses of a cell-based avian flu vaccine triggered a good immune response to the H5N1 avian influenza virus, according to preliminary results of a clinical trial by Baxter International of Deerfield, Ill., maker of the vaccine.

Pages

Sort Results

 

Narrow results

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»